Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
Cristina Fernandez,1 Clare L van Halsema1,21Regional Infectious Diseases Unit, North Manchester General Hospital, Manchester, UK; 2Faculty of Education, Liverpool School of Tropical Medicine, Liverpool, UKAbstract: Cabotegravir and rilpivirine long-acting injectable antiretroviral therapy for the tr...
Guardado en:
Autores principales: | Fernandez C, van Halsema CL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a09d2af3a9054c7f880cb8e75d206c4b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data
por: Rock AE, et al.
Publicado: (2020) -
Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date
por: Whitfield T, et al.
Publicado: (2016) -
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
por: Seth C. Inzaule, et al.
Publicado: (2018) -
Impacto de la terapia anti retroviral en la mortalidad de pacientes VIH (+) chilenos: estudio caso-control (MORTAR)
por: Wolff R,Marcelo, et al.
Publicado: (2000) -
Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients
por: Matthew Weichseldorfer, et al.
Publicado: (2021)